Linezolid-induced neuropathy

被引：31

作者：

Legout, L ^{[1
]}

Senneville, E

Gomel, JJ

Yazdanpanah, Y

Mouton, Y

机构：

[1] Dron Hosp, Dept Infect Dis, F-59208 Tourcoing, France

[2] Dron Hosp, Dept Neurol, F-59208 Tourcoing, France

来源：

CLINICAL INFECTIOUS DISEASES | 2004年 / 38卷 / 05期

关键词：

D O I：

10.1086/381762

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：767 / 768

页数：2

共 6 条

[1] In vitro activities of linezolid against multiple Nocardia species [J].

Brown-Elliott, BA ;

Ward, SC ;

Crist, CJ ;

Mann, LB ;

Wilson, RW ;

Wallace, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1295-1297

[2] Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents [J].

Ednie, LM ;

Jacobs, MR ;

Appelbaum, PC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) :101-105

[3] Hematologic effects of linezolid: Summary of clinical experience [J].

Gerson, SL ;

Kaplan, SL ;

Bruss, JB ;

Le, V ;

Arellano, FM ;

Hafkin, B ;

Kuter, DJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2723-2726

[4] Linezolid-associated toxic optic neuropathy: A report of 2 cases [J].

Lee, E ;

Burger, S ;

Shah, J ;

Melton, C ;

Mullen, M ;

Warren, F ;

Press, R .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (10) :1389-1391

[5] Linezolid penetration into osteo-articular tissues [J].

Rana, B ;

Butcher, I ;

Grigoris, P ;

Murnaghan, C ;

Seaton, RA ;

Tobin, CM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (05) :747-750

[6] Worldwide assessment of linezolid's clinical safety and tolerability: Comparator-controlled phase III studies [J].

Rubinstein, E ;

Isturiz, R ;

Standiford, HC ;

Smith, LG ;

Oliphant, TH ;

Cammarata, S ;

Hafkin, B ;

Le, V ;

Remington, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) :1824-1831

← 1 →